Nonarteritic Anterior Ischemic Optic Neuropathy and Semaglutide: What is This All About?
非動脈性前部缺血性視神經病變與 Semaglutide:這到底是什麼?
J Assoc Physicians India 2024-08-20
Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial.
Semaglutide和empagliflozin對2型糖尿病患者眼部氧合、血管自我調節和視網膜中央厚度的影響:一項隨機臨床試驗的預先指定次級分析。
J Diabetes Complications 2023-08-04
Prescription of glucagon-like peptide 1 agonists and risk of subsequent open-angle glaucoma in individuals with type 2 diabetes mellitus.
糖尿病患者使用胰高血糖素樣肽-1受體激動劑處方與後續開角型青光眼風險。
Int J Med Sci 2024-02-16
Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.
糖尿病患者中胰高血糖素樣肽-1受體激動劑與青光眼風險的關聯。
Ophthalmology 2024-05-04
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
二型糖尿病患者使用鈉葡萄糖共同轉運蛋白2抑制劑和葡萄糖依賴性胰高血糖素樣肽1受體激動劑的視網膜病變和糖尿病黃斑水腫風險:來自全球聯合數據庫的實證研究。
Diabetologia 2024-04-07
Association of sodium-glucose cotransporter-2 inhibitors and the risk of retinal vascular occlusion: A real-world retrospective cohort study in Taiwan.
鈉葡萄糖共同轉運蛋白-2抑制劑與視網膜血管阻塞風險的關聯:臺灣的實證回顧性cohort研究。
Diabetes Metab Res Rev 2024-04-12
Reversible bilateral central scotoma under scotopic conditions associated with oral semaglutide.
與口服 semaglutide 相關的可逆性雙側中央暗點在暗視條件下的表現。
Am J Ophthalmol Case Rep 2024-08-23